Stocks and Investing
Stocks and Investing
Tue, September 21, 2021
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mon, September 20, 2021
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Andrew Berens Initiated (TNGX) at Buy and Held Target at $25 on, Sep 20th, 2021
Andrew Berens of SVB Leerink, Initiated "Tango Therapeutics, Inc." (TNGX) at Buy and Held Target at $25 on, Sep 20th, 2021.
Andrew has made no other calls on TNGX in the last 4 months.
There are 3 other peers that have a rating on TNGX. Out of the 3 peers that are also analyzing TNGX, 0 agree with Andrew's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Andrew
- Charles Zhu of "Guggenheim" Initiated at Strong Buy and Held Target at $16 on, Tuesday, September 7th, 2021
- Chris Shibutani of "Goldman Sachs" Initiated at Strong Buy and Held Target at $17 on, Tuesday, September 7th, 2021
- Robert Driscoll of "Wedbush" Initiated at Buy and Held Target at $20 on, Tuesday, September 7th, 2021
Contributing Sources